...
首页> 外文期刊>Chinese Medicine >Effects of Qing’E Formula on the Expression of Bone Metabolic Markers and VDR mRNA in Postmenopausal Osteoporosis Patients
【24h】

Effects of Qing’E Formula on the Expression of Bone Metabolic Markers and VDR mRNA in Postmenopausal Osteoporosis Patients

机译:清’配方对绝经后骨质疏松症患者骨代谢指标和VDR mRNA表达的影响

获取原文
           

摘要

Objectives: To study the partial mechanism of treating postmenopausal osteoporosis patients (POPs) using the ancient recipe of Qing’E Formula (QEF) by observing its effects on bone metabolic markers and VDR mRNA expression in primary POPs. Methods: Analysis was performed on 120 outpatient and inpatient POPs treated in our hospital between January and October 2013, where the patients were randomly divided into Qing’E group (QEF + Caltrate), Calcitriol group (Caltrate + Calcitriol soft capsules), and Compare group (Caltrate), each with a follow-up period of 1 year. Statistical analysis was then performed on bone mineral density, blood bone metabolic markers (β-CTX, N-MID, T-PINP) and changes in VDR mRNA expressions in the POPs before and after the treatments. Results: Prior to the treatments, bone mineral density and blood β-CTX, N-MID, T-PINP and VDR mRNA expression in the 3 groups of POPs exhibited no statistically significant differences, and the blood β-CTX, N-MID, T-PINP and VDR mRNA expression in the control group showed no statistically significant differences before and after the treatments. There were no significant differences in bone mineral density in the Qing’E group and the Calcitriol group before and after the treatments whereas the bone mineral density decreased in the control group after the treatments. As for blood β-CTX, N-MID, T-PINP and VDR mRNA expression, the measurements in POPs in the Qing’E group and the Calcitriol group were significantly higher than that of the control group. Conclusion: By adjusting the VDR mRNA expression, the QEF, a kidney-invigorating Chinese herbal formula, is capable of activating bone metabolism to prohibit further losses of bone mass, thereby preventing the deterioration of osteoporosis.
机译:目的:通过观察古配方的Qing'E Formula(QEF)对原发性POPs骨代谢标志物和VDR mRNA表达的影响,研究治疗绝经后骨质疏松症患者(POPs)的部分机制。方法:对2013年1月至2013年10月在我院治疗的120例门诊和住院患者进行POPs分析,将患者随机分为清E组(QEF +钙盐),骨化三醇组(盐酸盐+骨化三醇软胶囊),并进行比较组(Caltrate),每个组的随访期为1年。然后对治疗前后POPs中的骨矿物质密度,血液骨代谢指标(β-CTX,N-MID,T-PINP)和VDR mRNA表达的变化进行统计分析。结果:治疗前,三组POPs的骨矿物质密度和血液β-CTX,N-MID,T-PINP和VDR mRNA表达无统计学差异,血液β-CTX,N-MID,对照组的T-PINP和VDR mRNA表达在治疗前后均无统计学差异。治疗前后,清Qing组和骨化三醇组的骨矿物质密度无显着差异,而对照组的骨矿物质密度下降。至于血液中β-CTX,N-MID,T-PINP和VDR mRNA的表达,清Qing组和骨化三醇组的POPs测量值明显高于对照组。结论:补肾益气中药QEF通过调节VDR mRNA的表达,能够激活骨代谢,阻止骨质进一步流失,从而预防骨质疏松的恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号